FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 3213631 · Received July 9, 2013

Report

Report Number
2124215-2013-10817
Event Type
Injury
Date Received
July 9, 2013
Date of Event
April 3, 2013
Report Date
April 3, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE LEAD WAS PERFORMED. ANALYSIS SHOWED THAT THERE WAS A TRILUMEN INSULATION DAMAGE. THIS TYPE OF DAMAGE MOST LIKELY CAUSED BY ENTRAPMENT IN THE CLAVICLE/ FIRST-RIB REGION. NO COIL FRACTURE WAS OBSERVED. LEAD PASSED CONTINUITY TEST.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR (RV) LEAD WAS FRACTURED AND EXHIBITED VARYING CHANGES IN IMPEDANCE. IN ADDITION, THIS LEAD EMITTED NOISE, HAD DECREASED AMPLITUDE AND DELIVERED INAPPROPRIATE SHOCKS. THIS RV LEAD WAS EXPLANTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
313505 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0185

Patients

Seq Age Sex Outcome Treatment
1 57 YR Hospitalization| L| R 4136| 4555| 5071| 0185| 4543| H170| 4087| N119